Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories
Anna V. Klepikova, Tatiana A. Nenasheva, О. Н. Шевелева, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16087-16087
Open Access | Times Cited: 18

Showing 18 citing articles:

Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases
Tarun Pant, Nnamdi Uche, Matea Juric, et al.
Redox Biology (2024) Vol. 70, pp. 103077-103077
Open Access | Times Cited: 27
Optimized Method to Generate Well-Characterized Macrophages from Induced Pluripotent Stem Cells
Qimin Hai, Peter Bazeley, Juying Han, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 99-99
Open Access
Bioengineering Approaches to In Vitro Modeling of Genetic and Acquired Cardiac Diseases
Linqi Jin, Boeun Hwang, Sarah Rezapourdamanab, et al.
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Open Access
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
The Pluripotent Path to Immunotherapy
Mame P. Diop, Sjoukje J. C. van der Stegen
Experimental Hematology (2024), pp. 104648-104648
Closed Access | Times Cited: 2
Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”
Mark Chandy, Thomas Hill, Nerea Jimenez-Tellez, et al.
Cardiovascular Toxicology (2024) Vol. 24, Iss. 5, pp. 435-471
Closed Access | Times Cited: 1
Generation of iPSCs from a Patient with the M694V Mutation in the MEFV Gene Associated with Familial Mediterranean Fever and Their Differentiation into Macrophages
Е. В. Григорьева, Lana V. Karapetyan, Anastasia A. Malakhova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6102-6102
Open Access | Times Cited: 1
Generation of immune cells from induced pluripotent stem cells (iPSCs): Their potential for adoptive cell therapy
Mahsa Gheitasi, Sepeher Safdel, Sananda Kumar Patra, et al.
Human Immunology (2024) Vol. 85, Iss. 5, pp. 110836-110836
Closed Access | Times Cited: 1
Recapitulation of NOD/RIPK2 signaling in iPSC-derived macrophages
Mozhgan Dehghan Harati, Jim King, Simon Langer, et al.
SLAS DISCOVERY (2024), pp. 100185-100185
Open Access | Times Cited: 1
Synergy between pluripotent stem cell‐derived macrophages and self‐renewing macrophages: Envisioning a promising avenue for the modelling and cell therapy of infectious diseases
Dingkun Peng, Meilin Li, Zhuoran Yu, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 1
Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells
Alexander Blümke, Jessica Simon, Elizabeth Leber, et al.
Journal of Visualized Experiments (2024), Iss. 205
Closed Access | Times Cited: 1
A Model of iPSC-Derived Macrophages with TNFAIP3 Overexpression Reveals the Peculiarities of TNFAIP3 Protein Expression and Function in Human Macrophages
О. Н. Шевелева, Elena A. Protasova, Tatiana A. Nenasheva, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12868-12868
Open Access | Times Cited: 3
Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
Jinhe Jiang, Rutong Ren, Yan-jie Cheng, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 11
Open Access
Early markers of induced pluripotent stem cell hematopoietic development
О. Н. Шевелева, Tatiana A. Nenasheva, Irina V. Lyadova
Medical Immunology (Russia) (2024) Vol. 26, Iss. 5, pp. 883-890
Open Access
Human organoids and organ-on-chips in coeliac disease research
H Simpson, Eline Smits, Renée Moerkens, et al.
Trends in Molecular Medicine (2024)
Open Access
The Generation of Genetically Engineered Human Induced Pluripotent Stem Cells Overexpressing IFN-β for Future Experimental and Clinically Oriented Studies
О. Н. Шевелева, Elena A. Protasova, Е. В. Григорьева, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12456-12456
Open Access
Smart Cell Therapy: an industry perspective on macrophages as living drugs
David T. Rodgers, Tatiana I. Novobrantseva, Rita N. Bárcia
Cytotherapy (2024)
Closed Access
Special Issue “Stem Cell Biology & Regenerative Medicine”
Rivka Ofir
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12855-12855
Open Access | Times Cited: 1
Page 1

Scroll to top